aztreonam has been researched along with nystatin a1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abrahams, C; Albert, H; Bosman, M; Mole, R; Trollip, A | 1 |
| Abrahams, C; Albert, H; Linley, K; Mole, RJ; Seaman, T; Trollip, AP | 1 |
1 review(s) available for aztreonam and nystatin a1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for aztreonam and nystatin a1
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aztreonam; Humans; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Nystatin; Oxacillin; Prospective Studies; Rifampin; Sensitivity and Specificity | 2007 |
Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Aztreonam; Culture Media; Drug Combinations; Drug Resistance, Bacterial; Equipment Contamination; Humans; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Nystatin; Oxacillin; Rifampin; Tuberculosis | 2007 |